Literature DB >> 7784289

Methotrexate-induced pericarditis and pericardial effusion; first reported case.

L N Forbat1, B W Hancock, A H Gershlick.   

Abstract

We report a case of methotrexate-induced pericarditis and pericardial effusion in a 22-year-old pregnant woman. These complications have not previously been described as isolated phenomena associated with methotrexate therapy.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7784289      PMCID： PMC2398071          DOI： 10.1136/pgmj.71.834.244

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  4 in total

1.  Use of bronchoalveolar lavage in the evaluation of methotrexate lung disease.

Authors:  G M Akoun; C M Mayaud; J L Touboul; M F Denis; B J Milleron; J Y Perrot
Journal:  Thorax       Date:  1987-09       Impact factor: 9.139

Review 2.  [Pneumopathy caused by methotrexate].

Authors:  F Massin; B Coudert; J P Marot; P Foucher; P Camus; L Jeannin
Journal:  Rev Mal Respir       Date:  1990       Impact factor: 0.622

Review 3.  Pulmonary effects of cytotoxic agents other than bleomycin.

Authors:  K J Twohig; R A Matthay
Journal:  Clin Chest Med       Date:  1990-03       Impact factor: 2.878

Review 4.  Pulmonary toxicity of cytotoxic and immunosuppressive agents. A review.

Authors:  G Lehne; K Lote
Journal:  Acta Oncol       Date:  1990       Impact factor: 4.089
  4 in total
  6 in total

1.  Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Juan Carlos Plana; Maurizio Galderisi; Ana Barac; Michael S Ewer; Bonnie Ky; Marielle Scherrer-Crosbie; Javier Ganame; Igal A Sebag; Deborah A Agler; Luigi P Badano; Jose Banchs; Daniela Cardinale; Joseph Carver; Manuel Cerqueira; Jeanne M DeCara; Thor Edvardsen; Scott D Flamm; Thomas Force; Brian P Griffin; Guy Jerusalem; Jennifer E Liu; Andreia Magalhães; Thomas Marwick; Liza Y Sanchez; Rosa Sicari; Hector R Villarraga; Patrizio Lancellotti
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-10       Impact factor: 6.875

Review 2.  Update on assessment and management of primary cardiac involvement in systemic sclerosis.

Authors:  Vasiliki-Kalliopi Bournia; Christos Tountas; Athanase D Protogerou; Stylianos Panopoulos; Sophie Mavrogeni; Petros P Sfikakis
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

3.  Case report: Methotrexate-induced pericardial effusion.

Authors:  Betül Dündar; Alper Karalök; Işın Ureyen; Burcu Gündoğdu; Reyhan Oçalan; Taner Turan; Nurettin Boran; Gökhan Tulunay; M Faruk Köse
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-03-01

4.  Pericarditis: a rare complication of methotrexate therapy.

Authors:  Tayyab Mohyuddin; Mazen Elyan; Irving Kushner
Journal:  Clin Rheumatol       Date:  2007-05-23       Impact factor: 2.980

5.  Serosal complications of single-agent low-dose methotrexate used in gestational trophoblastic diseases: first reported case of methotrexate-induced peritonitis.

Authors:  S Sharma; S Jagdev; R E Coleman; B W Hancock; P C Lorigan
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

6.  Low-risk persistent gestational trophoblastic disease treated with low-dose methotrexate: efficacy, acute and long-term effects.

Authors:  F Khan; J Everard; S Ahmed; R E Coleman; M Aitken; B W Hancock
Journal:  Br J Cancer       Date:  2003-12-15       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.